Coffee has been linked to various health benefits, including reduced risk of womb cancer and liver cancer. Now, research suggests coffee may lower risk of type 2 diabetes.
type
FDA approves Tanzeum to treat type 2 diabetes
The U.S. Food and Drug Administration today approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
New ammunition in the fight against Type 2 diabetes
Gastric banding can play a vital role in the treatment of type 2 diabetes in people who are overweight but not obese, according to new research.
Weight loss surgery treats type 2 diabetes in obese patients
New research published in the New England Journal of Medicine and presented at a scientific meeting shows that bariatric weight loss surgery is an effective and lasting treatment for type 2 diabetes in obese patients when compared with medical therapy.
Discovery of new pathway connected to type 2 diabetes
Scientists at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute have discovered a cellular pathway that is responsible for keeping blood sugar levels low in obese or pre-diabetic people, and may prevent the onset of Type 2 diabetes. The discovery is published this month in a leading journal Nature Cell Biology.
Older age at onset of type 1 diabetes associated with lower brain connectivity later in life
Children and adolescents older than age 8 at the onset of type 1 diabetes had weaker brain connectivity when tested later in life relative to those who had earlier ages of diagnosis, University of Pittsburgh Schools of the Health Sciences researchers discovered.
Gut microbiota networks may influence autoimmune processes in type 1 diabetes
The interactions of the gut microbiota in children with typical diabetes autoantibodies differ from that in healthy children. The fact that these differences already exist before antibodies are detectable in the blood adds to the growing evidence that microbial DNA, the so-called microbiome, may be involved in the development of autoimmune processes.
Discovery could lead to further advances against diseases tied to obesity and type II diabetes
Researchers at NYU Langone Medical Center have found that blocking the action of a key signaling molecule in the immune system known as Netrin-1 stalls chronic inflammation and insulin resistance tied to obesity and often derived from fatty diets.
Higher BMI raises risk of type 2 diabetes, high blood pressure
Two recent genetic studies expand the list of genes involved with body fat and body mass index, and their connection to major Western health problems: heart disease, high blood pressure and diabetes.